table of contents 
A mini overview of human proteomics and related methodologies such as mass …
|
- Tyres M, Mann M. From genomics to proteomics. Nature 2003;422(6928):193-7.
- Csete ME, Doyle JC. Reverse engineering of biological complexity. Science 2002;295(5560):1664-9.
- Hanash S. Disease proteomics. Nature 2003;422(6928):226-32.
- Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422(6928):198-207.
- Kallweit U, Börnsen OK, Kresbach GM, Widmer, HM. Matrix compatible buffers for analysis of proteins with matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1996;10(7):845-9.
- Dubois F, Knochenmuss R, Steenvoorden RJ, Breuker K, Zenobi R. On the mechanism and control of salt-induced resolution loss in matrix-assisted laser desorption/ionization. Eur J Mass Spectrom 1996;2(10):167-72.
- Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-80.
- Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005;4(4):409-18.
- Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I, Zheng P, Bonfrer JM, Verschuuren JJ, Jenster G, Verbeek MM, Luider TM, Smith PA. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 2005;4(9):1341-9.
- Carette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez JC. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer’s disease. Proteomics 2003;3(8):1486-94.
- Sanchez JC, Guillaume E, Lescuyer P, Allard L, Carette O, Scherl A, Burgess J, Corthals GL, Burkhard PR, Hochstrasser DF. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 2004;4(8):2229-33.
- Petricoin EF, Zoon KC, Kohn EC, Barret JC, Liotta LA. Clinical proteomics: translating benchside promise into bedside reality. Nature Rev Drug Discov 2002;1(9):683-95.
- Maddalo G, Petrucci F, Iezzi M, Pannellini T, Del Boccio P, Ciavardelli D, Biroccio A, Forli F, Di Ilio C, Ballone E, Urbani A, Federici G. Analytical assessment of MALDI-TOF imaging mass spectrometry on thin histological samples. An insight in proteome investigation. Clin Chim Acta 2005;357(2):210-8.
- Caldwell RL, Caprioli RM. Tissue profiling by mass spectrometry: a review of methodology and applications. Mol Cell Proteomics (2005);4:394-401. Review.
- Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P. Correcting common errors in identifying cancer-specific serum peptide signatures. Journal of Proteome Research 2005;4(4):1060-72.
rating: 0.00 from 0 votes | updated on: 30 Sep 2006 | views: 318 |
|
Answers to all your Biology Questions
